ROR1 and neoplasm: and colleagues indicated that SCFA enhanced CD25 expression and the secretion of IFN-γ and TNF-α in CAR-T cells targeting tyrosine kinase-like orphan receptor 1 (ROR1), resulting in anti-tumor effects in syngeneic murine melanoma and pancreatic cancer models (61).